Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Shehadeh

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
The Israel Medical Association Journal : IMAJ|May 21, 2004
Insulin pump therapy for 1-6 year old children with type 1 diabetesNaim Shehadeh, Tadej Battelino, Avinoam Galatzer, et al.
Diabetes Technology & Therapeutics|October 3, 2024
GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case ReportGida Ayada, Sagit Zolotov, Raya Cohen, et al.
Pediatric Surgery International|March 10, 2005
Effect of subcutaneous insulin on intestinal adaptation in a rat model of short bowel syndromeIgor Sukhotnik, Jorge Mogilner, Raanan Shamir, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin or Saxagliptin in Pediatric Type 2 DiabetesNaim Shehadeh, Timothy Barrett, Pietro Galassetti, et al.
Pituitary|April 15, 2018
Management of cystic prolactinomas: a reviewAfif Nakhleh, Naim Shehadeh, Irit Hochberg, et al.
Diabetes Research and Clinical Practice|April 18, 2020
Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trialRakesh Sahay, Khadijah Hafidh, Khier Djaballah, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2024
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)Naim Shehadeh, Pietro Galassetti, Nayyar Iqbal, et al.
Clinical and Experimental Hepatology|July 28, 2023
Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient miceTomer Adar, Meir Mizrahi, Yoav Lichtenstein, et al.
Clinical Trials (London, England)|August 28, 2019
Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetesMuhammad Yazid Jalaludin, Margarita Barrientos-Pérez, Mona Hafez, et al.
The Journal of Surgical Research|June 19, 2007
Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a ratIgor Sukhotnik, Modi Agam, Raanan Shamir, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
The Israel Medical Association Journal : IMAJ|May 21, 2004
Insulin pump therapy for 1-6 year old children with type 1 diabetesNaim Shehadeh, Tadej Battelino, Avinoam Galatzer, et al.
Diabetes Technology & Therapeutics|October 3, 2024
GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case ReportGida Ayada, Sagit Zolotov, Raya Cohen, et al.
Pediatric Surgery International|March 10, 2005
Effect of subcutaneous insulin on intestinal adaptation in a rat model of short bowel syndromeIgor Sukhotnik, Jorge Mogilner, Raanan Shamir, et al.
NEJM Evidence|February 6, 2024
Dapagliflozin or Saxagliptin in Pediatric Type 2 DiabetesNaim Shehadeh, Timothy Barrett, Pietro Galassetti, et al.
Pituitary|April 15, 2018
Management of cystic prolactinomas: a reviewAfif Nakhleh, Naim Shehadeh, Irit Hochberg, et al.
Diabetes Research and Clinical Practice|April 18, 2020
Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trialRakesh Sahay, Khadijah Hafidh, Khier Djaballah, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2024
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)Naim Shehadeh, Pietro Galassetti, Nayyar Iqbal, et al.
Clinical and Experimental Hepatology|July 28, 2023
Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient miceTomer Adar, Meir Mizrahi, Yoav Lichtenstein, et al.
Clinical Trials (London, England)|August 28, 2019
Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetesMuhammad Yazid Jalaludin, Margarita Barrientos-Pérez, Mona Hafez, et al.
The Journal of Surgical Research|June 19, 2007
Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a ratIgor Sukhotnik, Modi Agam, Raanan Shamir, et al.
Pageof 11